Tiziana Prochilo

Long-Term Results of Combined-Modality Therapy for Inflammatory Breast Carcinoma

Editta Baldini, G. Gardin, Giuseppe Evangelista et al. · Clinical Breast Cancer · 2004 · 75 citations

Medicine, Oncology, Breast Oncology +14

Concomitant versus sequential administration of epirubicin and paclitaxel as first‐line therapy in metastatic breast carcinoma

PierFranco Conte, Valentina Guarneri, Paolo Bruzzi et al. · Cancer · 2004 · 69 citations · Full text

Medicine, Oncology, Pharmacology +13

Accelerated versus standard cyclophosphamide, epirubicin and5-fluorouracil or cyclophosphamide, methotrexate and5-fluorouracil: a randomized phase III trial in locally advanced breast cancer

Editta Baldini, G. Gardin, Piergiorgio Giannessi et al. · Annals of Oncology · 2003 · 69 citations · Full text

Medicine, Oncology, Pharmacology +13

Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: Implications for clinical management

Michela Del Prete, Riccardo Giampieri, Fotios Loupakis et al. · Oncotarget · 2015 · 55 citations · Full text

Medicine, Oncology, Surgery +14

Cyclin A and E2F1 overexpression correlate with reduced disease-free survival in node-negative breast cancer patients.

Editta Baldini, Andrea Camerini, Alessandro Sgambato et al. · PubMed · 2007 · 35 citations

Medicine, Cancer Biology, Oncology +15